CPS1 and Hyperammonemia: Over the course of 3 weeks after initiating Cps1 genomic recombination, hyperammonemia and hyperglutaminemia ensue, with weight loss, sarcopenia, derangement of amino acids and, ultimately, death (Khoja et al., 2018).